$MRK

Letting $MRK cc exercise and let the shares go

$MRK back over $80

$INTC and $MRK both doing great, $IBM continuing rise to $140

$MRK nearing $77 level again, have cc's for tomorrow expiry at that level against my shares, last 3 weeks have all expired worthless, keep lowering the cost basis of the shares. Will surely loose them one of these weeks.

$MRK with a pop on FDA authorization of oral antiviral pill, will see if it lasts, have a $77 cc's against my shares expiring today

Have shares in $MRK still, didn't lose last week to cc, have $77 cc against half the shares for tomorrow expiry

$MRK trade is good

MRK 80 interesting prior resistance level

3070 $MRK MAR2022 $80 Cs trade 1.82

3070 $MRK MAR2022 $80 Cs trade 1.82

3057 $MRK Mar 2022 80.0 Calls trade $1.82 (CboeTheo=1.82) ASKSIDE [C2] IV=22.4% -1.2 OPENING Vol=3111, OI=2103,

perhaps of the news : FDA Expected To Authorize Pfizer, Merck COIVD Pills This Week $MRK $PFE

FDA EXPECTED TO AUTHORIZE PFIZER, MERCK COVID PILLS THIS WEEK $PFE $MRK

Might keep my $MRK shares after all, back below cc $76 strike price

Losing $MRK and $IBM shares to covered calls it looks like

4.2 Mil $MRK @ 76.7

2100 $MRK Mar22 67.5 Puts trade $2.20 (CboeTheo=2.18) ASKSIDE AMEX IV=26.4% -0.6 CROSS - OPENING Vol=2301, OI=139,

$MRK, breaks this level, this will make a very good long. Key support, extended from MA. Let see

$QQQ are opening flat and $SPY coming gap to the upside and the IWM also with a common gap to the upside. With the sell off on Friday, both $SPY & $QQQ are hovering around the 50MA. Usaully after a sell off we might see a bounce day/inside day. Good idea to look for stocks that are in need a bounce or that are extended to the downside. $WMT- Looking for a bounce/ dips towards 137-136 area to join trend. $MRK- Same idea, looking for flushes towards 72 area, good portion of the buying level is at that level and looking to join the dip buyers. If you know my strategy, I like to start with a starter towards that level and not add until I see confirmation. $DELL- gapping up, but like the daily chart, did not participate in the sell off, liking dips 58.5-58 area. $DIS- Like short towards 148-149 area. Keep an eye on the spy $C- liking after the downgrade at Morgan Stanley, will try short around median levels(63-63.5) $SNAP- I see more downside, liking pops towards $47 area $CRM- Looking for a bounce of this base and volume shelf. 253 is my long interest.

Sold MRK 70 puts .29 (small profits but good %)

Honorable mentions but are not focuses that did not make our intraday targets today MRK, EFX, KYMR, STT and CRXT

$MRK covid pill being reviewed today by FDA advisory panel for possible recommendation for emergency use designation. Could see some oversized moves.

MRK 12/03 70 puts .17 (Weekly breakdown occurring with recent downgrades, slow mover looking for a ramp up in activity)

$MRK surprising gap down on good news

Friday, November 26, 2021 Futures Up/Down % Last Dow -809.00 2.26% 34,940 S&P 500 -82.25 1.75% 4,617 Nasdaq -161.50 0.99% 16,204 Not exactly what U.S. investors were expecting on their return from the Thanksgiving Day holiday as U.S. equity futures are plunging, with the S&P looking lower by -1.6%, along with oil prices tumbling over 6% to $73.25 and bond yields crumbling over 13 bps to 1.51% as investors are worried that a new coronavirus variant identified in South Africa (called B.1.1.529) could spark fresh outbreaks. The EU, Britain, Singapore, and India among those announcing stricter border controls as scientists sought to determine if the mutation was vaccine-resistant. Reports indicate the variant has a spike protein that is dramatically different to the one in the original coronavirus that COVID-19 vaccines are based on, the UK Health Security Agency said raising fears that the current vaccines may be ineffective. Still, vaccine makers Pfizer (PFE), Moderna (MRNA), Novavax (NVAX) and Merck (MRK) are seeing shares soar early. In reverse, shares of travel, leisure, hotel stocks are seeing the biggest declines early. Asian stocks suffered their sharpest drop in two months on Friday after the detection of a new and possibly vaccine-resistant coronavirus variant sent investors scurrying toward the safety of bonds, the yen and the dollar. A handful of local COVID-19 cases in eastern parts of China have prompted Shanghai city to limit tourism activities and a nearby city to cut public transportation services; Shanghai city detected three domestically transmitted COVID-19 cases with confirmed symptoms for Nov. 25. In Asian markets, The Nikkei Index slides -2.5% or 750 points to 28,750, the Shanghai Index slips -20 points to 3,564 and the Hang Seng Index tumbles -659 points (2.67%) to 24,080. In Europe, the German DAX is craters -2.8% or 450 points to 15,460, while the FTSE 100 tumbles -210 points (2.87%) to 7,100. The variant concerns weighing on retailers as well ahead of the busiest shopping day of the year “Black Friday”. Market Closing Prices Yesterday · The S&P 500 Index gained 10.76 points, or 0.23%, to 4,701.46 · The Dow Jones Industrial Average fell -9.42 points, or 0.03%, to 35,804.38 · The Nasdaq Composite climbed 70.09 points, or 0.44%, to 15,845.23 · The Russell 2000 Index advanced 3.59 points, or 0.15% to 2,331.46 Events Calendar for Today · U.S. Equity Markets with an early 1:00 PM ET close Macro Up/Down Last Nymex -5.26 73.12 Brent -4.84 77.37 Gold 28.50 1,815.30 EUR/USD 0.0088 1.1294 JPY/USD -1.50 113.86 10-Year Note -0.13 1.514% World News · Britain banned flights from South Africa and neighboring countries and asked British travelers returning from there to quarantine, while European Commission chief Ursula von der Leyen said the EU also aimed to halt air travel from the region. · Volatility traders are rushing to bet on turmoil in the U.S. stock market as fears over a new strain of the coronavirus look set to finally end weeks of tranquil trading. The Cboe Volatility Index, or VIX, jumped as much as 9 points on Friday morning, the biggest intraday move since February Sector News Breakdown Consumer · Chinese regulators have asked top executives of ride hailing giant Didi Global Inc (DIDI) to devise a plan to delist from U.S. bourses on data security fears, Bloomberg News reported. China’s tech watchdog wants the management to take the company off the NYSE on concerns about leakage of sensitive data, the report said · The Brussels Court of Appeals ordered two of Uber’s (UBER) units to pay EUR 150,000, for a total of $336,600, when it backed a complaint made by a Brussels taxi firm – Bloomberg Energy, Industrials and Materials · Oil prices slid on concerns that a global supply surplus could swell in Q1 following a U.S.-led coordinated release of crude reserves (SPR) among major consumers and as a new COVID-19 variant spook investor. Oil prices likely dropped in tandem with wider financial markets on concerns the new variant would hit demand by limiting movements again Financials · KKR & Co (KKR) and CVC Capital Partners are considering teaming up on a bid for Italy-based Telecom Italia SpA, Bloomberg News reported on Thursday, citing people with knowledge of the matter · China Evergrande Group Chairman Hui Ka Yan cut his stake in the company for the first time since it went public in 2009, the latest sign he’s liquidating personal assets to help stave off a default by the world’s most indebted developer. Hui sold 1.2 billion Evergrande shares for the equivalent of $344 million on Thursday, according to a filing – Bloomberg Healthcare · Selecta Biosciences (SELB) announced that the FDA has placed a clinical hold on its Phase 1/2 clinical trial of SEL-302, (which consists of MMA-101 plus ImmTOR, for the treatment of patients with methylmalonic acidemia, or MMA) · Vaccine makers Pfizer (PFE), Moderna (MRNA), Novavax (NVAX) and Merck (MRK) are seeing shares soar early on the new virus variant news. Technology, Media & Telecom · Pinduoduo Inc (PDD) posted quarterly revenue that missed market estimates on Friday, hurt by stiff competition from rivals Alibaba and JD.com Inc amid the pandemic-driven online shopping boom. Total revenue was 21.51 billion yuan ($3.37 billion) in the third quarter, below analysts’ average estimate of 26.59 billion yuan, according to IBES data from Refinitiv. · United Microelectronics Corporation (UMC) and Micron Technology (MU) announced a settlement agreement between the two companies worldwide

Healthcare Alkermes ($ALKS) announced that it received notices of partial termination in respect of two license agreements with Janssen Pharmaceutica N.V., a subsidiary of Johnson & Johnson Acadia Pharmaceuticals Inc ($ACAD) 3Q EPS ($0.09) vs est. ($0.26) on sales $131.6Mm vs est. $127.8Mm, says narrows FY Nuplazid sales guide to $480-500Mm Castle Biosciences ($CSTL) 3Q EPS ($0.47) vs est. ($0.41) on revs $23.5Mm vs est. $23Mm; says on track to achieve FY total revs guide of $89-93Mm vs est. $91.9Mm Clover Health ($CLOV) Q3 revs $427.2M vs est. $413.1M, adj EBITDA ($102.3M) vs est. ($99.5M); sees FY revs $1.42B-$1.47B vs est. $1.44B Curaleaf holdings ($CURLF) Q3 revenue $317M vs est. $328.3M, adj EBITDA $71M vs est. $92.1M; remains on track to generate revenue within lower end of $1.2B-$1.3B annual guidance range; said the acquisition of Tryke Companies reported earlier today bolsters its position in NV, AZ, UT and will be immediately accretive to margins and cash flow Fluidigm Corp ($FLDM) 3Q EPS ($0.18) vs est. ($0.22) on revs $28.5Mm vs est. $30Mm; says undertaking review of various options including with regard to strategic alternatives Invitae Corporation ($NVTA) Q3 adj EPS ($0.81) vs est. ($0.71) on revenue $114.4M vs est. $126.5M driven by billable volume 296k (+89% YoY); now sees FY revenue $450M-$475M, from $475M-$500M and below est. $484.5M Mirati Therapeutics, Inc. ($MRTX) 3Q EPS ($1.55) vs est. ($2.89) on revs $71.8Mm Nevro Corp. ($NVRO) Q3 EPS loss ($1.44) vs. est. loss (-$0.87); Q3 rev $93.2M vs. est. $91.59M; sees Q4 revs $94M-$98M Oak Street Health, Inc. ($OSH) Q3 EPS loss (-$0.49) vs. est. loss (-$0.42); Q3 revs $388.7M vs. est. $356.7M; The Company cared for approximately 100,500 risk-based patients, representing 76% of its total patients; adjusted EBITDA was $(64.3M), compared to $(22.8M) YoY SI-BONE ($SIBN) Q3 EPS ($0.48) vs est. ($0.42) on revenue $22.3M vs est. $22.5M, lowered FY21 revenue view to $89M-$90M from $92M-$94M (vs est. $92.7M) as uncertainty surrounding Covid-19’s impact on elective procedures and healthcare infrastructure remains Shockwave Medical ($SWAV) Q3 EPS $0.05 vs. est. loss (-$0.06); Q3 revs $65.2M vs. est. $61.2M; sees FY21 revenue $227M-$228M vs. est. $223.43M, which represents 235% to 236% growth YoY SmileDirectClub, Inc. ($SDC) shares fall -23%; 3Q EPS ($0.23) vs est. ($0.13) on revs $138Mm vs est. $$181Mm; guides FY revs $630-650Mm vs est. $757Mm Tactile Systems ($TCMD) shares fell -12%; 3Q EPS ($0.17) vs est. $0.12 on revs $52.5Mm vs est. $57.4Mm; sees FY revs +9-10% or $203.5M-$206M from $216.3M-$224.5M, below est. +18.7% Merck ($MRK) said the U.S. government will buy 1.4 million additional courses of their COVID-19 pill, molnupiravir, for about $1 bln and that the U.S. has now committed to purchase a total of about 3.1 million courses of molnupiravir for about $2.2 billion Haemonetics ($HAE) Q2 adj EPS $0.60 vs. est. $0.61; Q2 revs $239.9M vs. est. $241.4M; lowers FY22 adj EPS view to $2.40-$2.65 from $2.60-$3.00 and narrows its FY22 revenue view to up 13%-17% from up 13%-18% Technology, Media & Telecom Bandwidth Inc. ($BAND) Q3 adj EPS $0.25 vs. est. $0.08; Q3 revs $130.6M vs. est. $125.3M; guides Q4 EPS loss (15c-11c) vs. est. loss (-$0.01); sees Q4 revs $115.7M-$120.7M vs. est. $125.5M 3D Systems ($DDD) 3Q adj EPS $0.08 vs est. $0.05 on revs $156.1Mm vs est. $144.8Mm; guides FY adj gr mgn 41-43% vs est. 42.7% Five9 Inc. ($FIVN) 3Q adj EPS $0.28 vs est. $0.23 on revs $154.3Mm vs est. $146.8Mm; guides 4Q revs $164.5-165.5mm vs est. $157.8Mm, sees 4Q adj EPS $0.36-0.37 vs est. $0.34; sees FY revs $$600.5-601.5Mm vs est. $585.2Mm and adj EPS $1.09-1.10 vs est. $1.02 Instructure Holdings, Inc. ($INST) 3Q EPS ($0.10) vs est. $0.14 on revs $107.2Mm vs est. $101.1Mm; sees 4Q revs $106.9-107.9Mm vs est. $104.1Mm; guides FY revs $401.7-402.7Mm vs est. $397.4Mm, sees FY adj EBITDA $143.6-144.6Mm vs est. $130Mm Luminar Technologies, Inc. ($LAZR) shares rise 50%; said at the NVIDIA GTC conference that its lidar solution has been selected to be part of the sensor suite in the NVIDIA DRIVE Hyperion autonomous vehicle reference platform. This AI vehicle computing platform accelerates development of autonomous consumer vehicles with planned production starting in 2024. New Relic ($NEWR) Q2 adj EPS loss (10c) vs. est. loss (13c); Q2 revs $196M vss. Est. $182.21M; cuts FY22 adj EPS loss view to (60c)-(54c) from (52c)-(49c) while boosts FY22 revenue view to $778M-$782M from $730M-$735M (est. $736.8M) National CineMedia ($NCMI) Q3 EPS loss (19c) vs. est. loss (13c); Q3 revs $31.7M vs. est. $41.24M; Q3 adjusted OIBDA improved to negative $8.2 million for the third quarter of 2021 from negative $11.2 million for the third quarter of 2020 Roblox ($RBLX) shares rise 29%; Q3 EPS (13c) vs est. (14c) on bookings $637.8M vs est. $636.5M, revenue $509.5M, avg DAUs 47.3M vs est. 46.6M, hours engaged 11.2B (+28% YoY), avg booking per DAU $13.49 Sanmina ($SANM) Q4 adj EPS $0.95 vs. est. $0.99; Q4 revs $1.64B vs. est. $1.7B; sees Q1 adj EPS 90c-$1.00 vs. est. $1.01; sees Q1 revs $1.6B-$1.7B below consensus $1.76B Square Space ($SQSP) Q3 EPS 4c vs est. 14c on revenue $201M vs est. $205.2M; sees Q4 revenue $203M-$206M vs est. $205.2M, raised annual revenue forecast to $780M-$783M from $772M-$780M (est. $778.4M) and unlevered FCF to $117M-$122M from $102M-$116M TripAdvisor ($TRIP) 3Q adj EPS $0.16 vs est. $0.24 on revs $303Mm vs est. $304.4Mm; avg monthly unique users on branded websites rose to about 76% of 2019 comparable period; says CEO will step down during 2022 Vuzix Corporation ($VUZI) Q3 EPS loss (-$0.13), in-line with ests; Q3 revs $3.02M vs. est. $3.79M; General and Administrative expense for the three months ended September 30, 2021 was $3.1 million versus $1.6 million for the comparable 2020 period Xperi Holding Corporation ($XPER) 3Q adj EPS $0.53 vs est. $0.34 on res $219.4Mm vs est. $215.4Mm; guides FY revs $870-890Mm vs est. $882.2Mm Zynga ($ZNGA) 4Q EPS ($0.04) vs est. $0.07 on revs $704.7Mm vs est. $666Mm, qtrly bookings $668Mm +6%, average mobile DAUs 38Mm +21%, qtrly avg mobile MAUs 183Mm +120%; sees FY revs $2.78B vs est. $2.81B, sees FY bookings $2.814B

$MRK and $PFE leading the race

whats up with $MRK?

$PFE flying on anti viral treatment, $MRK down big on the news

$MRK covid antiviral pill approved for use in UK

2800 $MRK JAN2022 $87.5 Cs trade 3.3-3.45

2800 $MRK JAN2022 $87.5 Cs trade 3.3-3.45

Thursday, October 28, 2021 Futures Up/Down % Last Dow 54.00 0.15% 35,443 S&P 500 11.25 0.26% 4,556 Nasdaq 74.50 0.47% 15.662 U.S. futures are looking at a rebound after a late day swoon erased record gains for stocks, as markets again await another earnings barrage, with yesterday and today the two busiest days of the quarter. Drama out of Washington D.C. also adding to the volatility as investors remain hopeful on a spending bill. As for Wednesday, a midday all-time high for the Nasdaq 100 was marred by a late day sell-off in U.S. stocks, as the S&P 500 and Dow each retreated from records set just the previous day, led by weakness in energy stocks as oil prices tumbled from 7-year highs and long-dated Treasury yields also slumped, with the 30-year falling as much as 10bps below 2%. Corporate earnings have generally been better-than-expected, but constant reminders about rising costs, supply-chain issues, and labor shortages on conference calls brings into question the strength of markets going forward. Couple that with expectations for the Fed to begin its asset tapering plans in November and chances of interest rate hikes in mid-2022 to help prevent inflation getting further out of hand remains a market concern. Shares of Dow components McDonald’s, Coca-Cola and Microsoft rallied behind strong earnings. In fact, the Nasdaq outperformed behind large cap winners (TSLA, GOOGL MSFT, AMZN), though breadth was decisively negative and SmallCaps plunged with the Russell 200 falling nearly 2%. President Biden’s infrastructure and social-spending plans still remain “up-in-the-air” which also adds uncertainty. In Asian markets, The Nikkei Index fell about 1% to 28,820, the Shanghai Index slipped -1.23% to 3.518 and the Hang Seng Index dipped about -0.25% to 25,555. In Europe, the German DAX is down -0.15% at 15,680, while the FTSE 100 is also down roughly -0.2% at 7,240. Market Closing Prices Yesterday The S&P 500 Index dropped -23.11 points, or 0.51%, to 4,551.68 The Dow Jones Industrial Average fell -266.19 points, or 0.74%, to 35,490.69 The Nasdaq Composite little changed, or 0.00%, to 15,235.84 The Russell 2000 Index declined -43.58 points, or 1.90% to 2,252.49 Events Calendar for Today 8:30 AM ET Weekly Jobless Claims…est. 290K 8:30 AM EST Continuing Claims…est. 2.415M 8:30 AM ET Gross Domestic Product (GDP) for Q3-A…est. 2.7% (down from prior) 8:30 AM ET GDP Consumer Spending for Q3-A…prior month 12.0% 8:30 AM ET GDP Price Deflator for Q3…est. 5.5% 8:30 AM ET Core-PCE Prices Advance for Q3…est. 4.5% 10:00 AM ET Pending Home Sales MoM for September…est. 0% 10:30 AM ET Weekly EIA Natural Gas Inventory Data 11:00 AM ET Kansas City Fed Manufacturing for October 1:00 PM ET U.S. to sell $62 bln 7-year notes Earnings Calendar: Earnings Before the Open: AB, ABMD, ADS, AEP, AGCO, ALNY, AMT, AOS, ATI, BAX, BC, BSIG, BTU, CARR, CAR, CBRE, CBZ, CFR, CG, CMCO, CMCSA, CMS, CNX, COLB, CONE, COOP, COR, CWT, DBD, EME, EXP, FCN, GPI, GVA, HBAN, HSY, IBP, ICE, ITW, KBR, KDP, KEX, LECO, LH, LKQ, MA, MCO, MDD, MO, MRK, NEM, NLSN, NOC, OSK, OSIS, OSTK, PBF, RGEN, RLGY, RS, SAH, SAIA, SNDR, SWI, SWK, TAP, TFX, TPX, TREE, TW, TXT, VC, VLY, WEX, WST, XEL, YUM Earnings After the Close: AAPL, ABCB, ACHC, AGL, AMZN, ASPN, ATEN, ATR, AVT, AX, BIO, BY, CDNA, CHE, COHU, COLM, CPT, CUZ, CWST, DECK, DVA, DXCM, EB, EMN, FISI, FTDR, FTV, GILD, HIG, HUBG, LOPE, LPLA, LTC, NGRC, MHK, MMSI, MPWR, MSTR, NATI, NXGN, PEB, POWI, PSB, PTCT, QUMU, RMD, RSG, SBCF, SBUX, SGEN, SKX, SKYW, SM, SPNE, SSNC, SYK, TEX, TXRH, VCRA, VRSN, WDC, WRAP, WRE, X, ZEN Macro Up/Down Last Nymex -1.61 81.05 Brent -1.37 83.21 Gold -2.10 1,801.20 EUR/USD -0.0006 1.1598 JPY/USD -0.23 113.57 10-Year Note +0.012 1.541% Sector News Breakdown Consumer eBay Inc. (EBAY) 3Q adj EPS $0.90 vs est. $0.89 on revs $2.5B vs est. $2.46B; guides 4Q adj EPS $0.72-0.76 vs est. $1.00, sees 4Q revs $2.57-2.62B vs est. $2.65B; raising estimated FY share buyback from $5.0B to $7.0B Ford Motor (F) announces resumption of stock dividend in 4q; 3Q adj EPS $0.51 vs est. $0.27 on revs $35.7B vs est. $32.5B; expects cash flow over current planning period to be more than sufficient to fund growth, announces resumption of regular stock dividend in 4Q; no changes to FY adj FCF guide of $4.0-5.0B Boot Barn (BOOT) Q2 EPS $1.25 vs est. $0.93 on revenue $312.7M (+67.1% vs 2Q19) vs est. $291M, same-store sales +61.7% YoY, +53.6% vs 2019; sees new unit growth 10% in FY22; named Jim Watkins as CFO with current CFO Greg Hackman continuing as VP and COO Churchill Downs (CHDN) 3Q EPS $1.57 vs est. $1.47 on revs $393Mm vs est. $406.8Mm Fresh Del Monte Produce Inc. (FDP) said it is raising prices on bananas, pineapples and fresh-cut fruit in response to unprecedented market conditions and inflationary pressures being felt across all industries iRobot (IRBT) Q3 EPS $1.67 vs. est. $0.70; Q3 revs $440.7M vs. est. $417.04M; cuts FY21 non-GAAP EPS view to $1.15-$1.74 from $2.25-$3.15 (est. $2.70) and lowers FY21 revenue view to $1.56B-$1.59B from $1.55B-$1.62B (est. $1.58B) Noodles (NDLS) Q3 adj EPS 12c vs est. 9c on in-line revenue $125.1M with digital sales 52% of total revs; system-wide comp sales +16.3% vs est. +14.3%, avg unit volume $1.38M, +16% YoY; now sees 7-9 new restaurants in 2021, down from prior outlook for 10-15; anticipates system-wide unit growth of at least 8% next year O’Reilly Auto (ORLY) Q3 EPS $8.07 vs. est. $7.18; Q3 sales $3.48B vs. est. $3.3B; gross profit margin 52.3% vs. 52.4% y/y; raises year rev outlook to $12.9B-$13.2B from prior $12.3B-$12.6B (est. $12.73B) Sleep Number (SNBR) 3Q EPS $2.22 vs est. $1.44 on revs $640Mm vs est. $587.1Mm; sees FY EPS $7.25 vs est. $7.15; Spirit Airlines (SAVE) Q3 adj EPS ($0.69) was a narrower loss than est. ($1.02) on in-line revs $922.6M; load factor 77.6%, capacity +3.5% vs 3Q19; is slowing the pace to push back to full fleet utilization, expects to produce 53B-55B available seat miles in 2022 VICI Properties (VICI) 3Q adj FFO/shr $0.45 on revs $375.7Mm; guides FY adj FFO/shr $1.7901.80 vs est. $1.84 Wyndham Hotels (WH) 3Q EPS $1.09 vs est. $0.91 on net revs $463Mm vs est. $463Mm; guides FY RevPAR growth about 43%, sees fee-related and other revs $1.21-1.23B; guides FY adj EPS $2.93-3.03 vs est. $2.69 Yum China (YUMC) Q3 adj EPS $0.22 vs. est. $0.31; Q3 revs $2.55B vs. est. $2.51B; qtrly total system sales increased 1% year over year, with increases of 1% at both KFC and Pizza Hut, excluding f/x; increasing gross new stores target to over 1,700 in 2021; expect that covid-19, especially the delta variant outbreaks, will continue to affect consumer behavior and impact our same-store sales recovery. Solo Brands, Inc. (DTC) prices 12.9M share IPO at $17.00 per share Scientific Games Corp (SGMS) announces sale of lottery business to Brookfield business partners for $6.05 billion; deal consisting of $5.825 bln in cash & an earn-out of up to $225 mln based on achievement of certain ebitda targets in 2022 & 2023 Energy, Industrials & Materials Allison Transmission (ALSN) 3Q EPS $0.89 vs est. $0.90 on revs $567Mm vs est. $584Mm; guides FY sales $2.325-2.4B vs est. $2.36B Flowserve Corp. (FLS) 3Q adj EPS $0.29 vs est. $0.40 on revs $866.1Mm vs est. $899Mm; guides FY revs down 2-4% vs est. -2.3%, sees FY EPS $1.45-1.65 (was $1.40-1.45) vs est. $1.58, sees CAPEX $70-80Mm vs prior $65Mm Kraton (KRA) Q3 adj EPS $0.98 vs. est. $0.79; Q3 revs $526.9M vs. est. $459.1M; Polymer segment operating income of $43.8 million, compared to an operating loss of $5.1 million YoY; Chemical segment operating income of $35.7M, compared to an operating loss of $401.7M YoY Sunnova Energy (NOVA) Q3 EPS ($0.25) vs est. ($0.13) on revenue $68.9M vs est. $67.4M; reaffirmed FY21 view for adj EBITDA $80M-$85M, customer additions 55k-58k; set FY22 guidance for adj EBITDA $117M-$137M, customer additions 83k-87k Tronox Holdings (TROX) Q3 adj EPS $0.72 vs. est. $0.64; Q3 revs rose 29% to $870M vs. est. $905.3M United Rentals (URI) 3Q adj EPS $6.58 vs est. $6.80 on revs $2.6B vs est. $2.58B; guides FY revs $9.6-9.75B vs est. $9.6B, sees FY adj EBITDA $4.325-4.4B vs est. 4.3B Financials Aflac (AFL) Q3 adj EPS $1.53 vs. est. $1.32; Q3 revs $5.2B vs. est. $5.34B; in yen terms, Aflac Japan’s net premium income was ¥323.1 bln for quarter, or 4.0% lower than a year ago AvalonBay (AVB) Q3 core FFO $2.06 vs est. 1.97, EPS $0.56 vs est. $0.77, same-store sales +1.2%; sees Q4 core FFO $2.19-$2.29 vs est. $2.11, raised FY core FFO view to $8.18-$8.28 from $7.92-$8.12 CyrusOne Inc. (CONE) 3Q adj FFO/shr $1.02 vs est. $0.99 on revs $304.1Mm vs est. $290.4Mm; guides FY revs $1.18-1.2B vs est. $1.17B Invitation Homes (INVH) Q3 core FFO 38c/shr vs est. 36c, EPS 12c vs est. 10c, revenue $510M vs est. $497.8M; same-store NOI +11.9% YoY on same-store revs +7.9%; raised FY21 core EPS view to $1.49 at midpoint from $1.44, adj FFO ro $1.28 at midpoint from $1.24 Lending Club (LC) Q3 EPS $0.26 vs est. $0.03 on revenue $246.2M vs est. $221.2M; sees Q4 revs $240M-$250M vs est. $235.7M, loan originations $2.8-$3B; raised FY view for revenue to $796M-$806M from $750M-$780M Raymond James (RJF) Q4 EPS $2.06 vs. est. $1.71; Q4 revs $2.7B vs. est. $2.54B; quarter-end records for client assets under administration of $1.18 trillion, financial assets under management of $191.9B, and net loans at Raymond James Bank of $25B The SEC asked at least one asset manager not to proceed with plans for a leveraged bitcoin exchange-traded fund, according to a person familiar with the matter. The SEC indicated it wants to limit new bitcoin-related products to those that provide unleveraged exposure to bitcoin futures contracts, such as the ProShares Bitcoin Strategy exchange-traded fund, which was launched last week, the person said. https://on.wsj.com/3GvG2qg Healthcare Align Technology (ALGN) 3Q adj EPS $2.87 vs est. $2.60 on revs $1.02B vs est. $978Mm; guides FY revs $3.9-3.95B vs est. $3.94B; says clinical study validates benefits of the Itero Element 5D imaging system Alnylam (ALNY) reports positive topline 18-month results from Helios-a phase 3 study of Vutrisiran in patients with HATTR amyloidosis with polyneuropathy BioMarin (BMRN) Q3 GAAP EPS loss (-$0.20) vs. est. loss (-$0.25); Q3 revs $408.7M vs. est. $435.32M; Lower Kuvan product revenues primarily due to generic competition due to the loss of exclusivity in the U.S.; Lower Aldurazyme product revenues due to timing of product fulfillment to Genzyme Edwards LifeSciences (EW) Q3 EPS $0.54 vs. est. $0.53; Q3 revs $1.3B vs. est. $1.32B; sees FY21 adjusted EPS at high end of $2.07-$2.27 (est. $2.26) and reaffirms FY21 revenue view $5.2B-$5.4B (est. $5.32B); TAVR sales grew 15%; underlying 14%; U.S. TAVR sales grew 12%; OUS approximately 20% Encompass Health (EHC) Q3 adj EPS $1.03 vs. est. $1.06; Q3 revs $1.28B vs. est. $1.31B; cuts FY21 adj EPS view to $4.23-$4.38 from $4.32-$4.47 and lowers FY21 revenue view to $5.08B-$5.13B from $5.1B-$5.25B (est. $5.18B) Molina Healthcare (MOH) Q3 adj EPS $2.83 vs. est. $2.79; Q3 revs $7.04B vs. est. $6.79B; backs FY21 EPS view of no less than $13.25 vs. est. $13.38 and backs FY21 revenue view of no less than $27.5B vs. est. $26.97B; consolidated MCR for Q3 was 88.9%, compared to 85.9% in the third quarter of 2020 Teladoc (TDOC) Q3 EPS loss (-$0.53) vs. est. loss (-$0.65); Q3 revs $521.66M vs. est. $516.6M; Q3 visits topped 3.9M, 37% higher than Q3 2020; sees Q4 EPS loss (73c)-(53c) vs. est. loss (69c); sees Q4 revs $536M-$546M vs. est. $539.74M; sees Q4 total visits 3.9M-4.1M

Thursday, October 21, 2021 Futures Up/Down % Last Dow -101.00 0.28% 35,376 S&P 500 -10.25 0.24% 4,517 Nasdaq -22.50 0.15% 15,355 U.S. futures are down slightly overnight, as the S&P 500 index comes into the day with a 6-day win streak, as the earnings barrage continues today, with shares of TSLA and IBM slipping after quarterly results last night while media giant AT&T (T) rises early following its results. For the moment, China Evergrande debt contagion fears, inflation, Fed tapering, rising commodity prices are having no effect on global stock markets with the CBOE Volatility index (VIX) settling around its lowest levels in about 2-months. As for yesterday, the Dow Jones Industrial Average touched an all-time fresh intraday high while the S&P 500 flirted with its all-time intraday record highs (rising a 6th straight day) after strong earnings results and forecasts from healthcare companies and as banks advanced amid rising Treasury yields. The 10-Year Treasury yield spiked to 1.6730% early, a fresh five-month high sending the S&P 500 Bank Index higher for a fifth-straight day, for its fourth-straight record close. Technology underperformed as the Nasdaq Composite closed slightly lower as inflation fears crept into the market late day following comments from Federal Reserve President Quarles. In Asian markets overnight, The Nikkei Index fell -546 points (1.87%) to settle at 28,708, the Shanghai Index inched higher 7-points to 3,594 and the Hang Seng Index declined -118 points to 26,017. In Europe, the German DAX is down just a few points holding above 15,500, while the FTSE 100 slips -0.3% to just under 7,200. Market Closing Prices Yesterday The S&P 500 Index gained 16.56 points, or 0.37%, to 4,536.19 The Dow Jones Industrial Average rose 152.03 points, or 0.43%, to 35,609.34 The Nasdaq Composite dropped -7.41 points, or 0.05%, to 15,121.68 The Russell 2000 Index advanced 13.85 points, or 0.61% to 2,289.77 Events Calendar for Today 8:30 AM ET Weekly Jobless Claims…est. 300K 8:30 AM EST Continuing Claims…est. 2.55M 8:30 AM ET Philly Fed Index for October…est. 25.0 10:00 AM ET Existing Home Sales MoM for September…est. 6.09M 10:00 AM ET Leading Index MoM for September…est. +0.4% 10:30 AM ET Weekly EIA Natural Gas Inventory Data Earnings Calendar: Earnings Before the Open: AAL, ALK, ALLY, AMTB, AN, BANC, BHLB, BKU, BX, CROX, DHX, DHR, DOW, EEFT, EWBC, FAF, FCX, GATX, GPC, GTLS, HOMB, HRI, IIIN, IPG, IQV, KEY, LNN, MMC, POOL, SASR, SCHN, T, TPH, TRN, TSCO, UNP, VLO, WBS Earnings After the Close: ASB, NJRI, BOOM, CE, CMG, CSL, CSTR, FFBC, GBCI, INTC, MAT, NUE, OZK, PBCT, PINE, PSMT, SAM, SNAP, SIVB, TRST, USX, VICR, WAL, WHR, WRB, WSFS Other Key Events: The European Society of Gene and Cell Therapy (ESGCT) Congress 2021 is taking place virtually this year from October 19-22 Macro Up/Down Last Nymex -0.53 82.89 Brent -0.95 84.87 Gold 1.90 1,788.70 EUR/USD -0.0012 1.1639 JPY/USD -0.27 113.99 10-Year Note +0.013 1.645% Sector News Breakdown Consumer Tesla Inc. ($TSLA) 3Q adj EPS $1.86 vs est. $1.59 on revs $13.76B vs est. $13.63B, auto gr margin 30.5% vs 27.7% year ago, says expect op margin will continue to grow; qtly bitcoin-related impairment of $51Mm; continue to target first model Y production builds in Berlin and Austin before end of year; says challenges including semi shortages, port congestion, rolling blackouts impacting ability to keep factories running full speed; Las Vegas ($LVS) Q3 revs $857M below the $1.34B estimate; on a GAAP basis, qtrly total net revenues for SCL increased to $611 mln, compared to $167 mln in q3 of 2020; Q3 adj EPS loss (-$0.45) vs. est. loss (-$0.20) Unilever ($UL) rises on higher-than-expected Q3 sales growth; reports higher-than-expected underlying sales growth for Q3 beating analysts’ expectations; reiterates full-year profit margin forecast, defying some analysts’ fears of a cut; warns inflation is likely to accelerate next year Portillo’s ($PTLO)27M share IPO priced at $20.00 Energy Kinder Morgan ($KMI) Q3 adj EPS $0.22 vs. est. $0.24; Q3 revs $3.82B vs. est. $3.26B; backs FY21 adjusted EBITDA view $7.9B, expects to generate net income attributable to KMI of $1.7 billion and declare dividends of $1.08 per share, a 3% increase TechnipFMC ($FTI) shares fall -6%; 3Q adj EPS ($0.06) vs est. $0.02 on revs $1.58B vs est. $1.7B, qtrly total inbound orders were $1.37B, qtr-end backlog $7.0B; guides FY subsea revs $5.2-5.5B, sees FY surface tech revs $1.05-1.25B, sees FY CAPEX approx $250Mm HighPeak Energy ($HPK)2M share Secondary priced at $10.00 Helix Energy ($HLX) narrows FY21 revenue view to $600M-$645M from $600M-$670M; narrows FY21 adjusted EBITDA view to $85M-$100M from $75M-$100M and boosts FY free cash flow view to $80M-$120M from $45M-$90M; lowers cap-ex view Valero (VLO) Q3 adj EPS $1.22 vs. est. $0.92; Q3 revs $29.52B vs. est. $23.97B Financials Discover Financial ($DFS) Q3 EPS $3.54 vs. est. $3.53; Q3 revs $2.78B vs. est. $2.91B; Total loans ended the quarter at $89.5 billion, up 1% year-over-year, and up 2% sequentially. Credit card loans ended the quarter at $70.3 billion, up 1% year-over-year. Personal loans decreased $321 million, or 4%, and private student loans increased $168 million, or 2%, year-over-year. Banner Corp. ($BANR) 3Q EPS $1.44 vs est. $1.15 on revs $155.5Mm vs est. $122.6Mm Cohen & Steers ($CNS) 3Q adj EPS $1.06 vs est. $0.97 on revs $154.2Mm vs est. $148.3Mm Equifax ($EFX) 3Q adj EPS $1.85 vs est. $1.72 on revs $1.2B vs est. $1.18B; guides 4Q revs $1.23-1.25B vs est. $1.2B and adj EPS $1.72-1.82 vs est. $1.80; sees FY revs $4.9-4.92B vs est. $4.83B and adj EPS $7.52-7.62 vs est. $7.47 First Industrial Realty ($FR) 3Q FFO/share $0.51 vs est. $0.49; raises FY FFO/share guide by $0.02 at midpoint to $1.95 vs est. $1.94 OneMain Holdings ($OMF) 3Q adj EPS $2.37 vs est. $2.30; C&I managed receivables $19.1B, C&I net charge-off ratio 3.52%, repurchased 2.4Mm shares for $141Mm in qtr; proposes minimum qtrly div/share of $0.70; Sterling Bancorp. ($STL) 3Q adj EPS $0.52 vs est. $0.51; NII $213.8Mm vs est. $219.3Mm; proposes 3Q dividend of $0.07 SL Green Realty ($SLG) Q3 FFO $1.78 vs. est. $1.58; Q3 revs $142.7M vs. est. $160.97M; revising its earnings guidance ranges; said same-store cash NOI, including our share of same-store cash NOI from unconsolidated joint ventures, increased by 5.7% for Q3; narrows FY21 FFO view to $6.45-$6.65 from $6.30-$6.70 SLM Corp. ($SLM) 3Q core EPS $0.24 vs est. $0.20; private education loan originations +10% to $2.1B; declares 4Q dividend of $0.11/share vs $0.03/share in 3Q21; qtrly NII $358Mm vs est. $343.6Mm; qtrly education loan provisions for credit losses $138Mm; sees FY net charge-offs $195M to $205M, saw $215M to $225M Texas Capital ($TCBI) Q3 EPS $0.76 vs. est. $1.10; Q3 net interest income of $194.1M declines from $197.0M in Q2 and $207.6M YoY due to a decline in loan fees, partially offset by a decrease in average interest-bearing deposits; non-interest income also fell 30% from Q2 and 65% from Q3 2020, driven by Q2 sale of its mortgage servicing rights portfolio and other non-interest income. Triumph Bancorp ($TBK) Q3 EPS $0.94 vs est. $1.08; Q3 net charge-offs .08%; Q3 CET1 capital ratio 9.45%; Q3 tangible book value per share $19.73; net interest margin was 6.69%. Yield on loans and the average cost of our total deposits were 7.92% and 0.16%, respectively Umpqua Holdings Corporation ($UMPQ) Q3 EPS $0.49 vs. est. $0.44; Net income of $108.1 million, or $0.49 per common share; non-PPP loan balances increased $479.7 million or 2.3%; Deposit balances increased $754.8 million or 2.9%; provision for credit losses recapture of $18.9 million as modeled economic conditions improve Healthcare S. regulators on Wednesday signed off on extending COVID-19 boosters to Americans who got the Moderna (MRNA) or Johnson & Johnson ($JNJ) vaccine and said anyone eligible for an extra dose can get a brand different from the one they received initially. Tenet Healthcare ($THC) Q3 adj EPS $1.99 vs. est. $0.99; Q3 revs $4.89B vs. est. $4.81B; qtrly same-hospital net patient service revenue per adjusted admission up 6.2% versus q3 2020; sees 2021 adj EPS now $6.15-$6.38 (from prior $5.23-$5.73) and adj Ebitda $3.275B-$3.325B (from prior $3.15B-$3.25B) Regeneron ($REGN) and Sanofi ($SNY) said the FDA has approved Dupixent, or dupilumab, as an add-on maintenance treatment of patients aged 6 to 11 years with moderate-to-severe asthma characterized by an eosinophilic phenotype or with oral corticosteroid-dependent asthma Ventyx Biosciences ($VTYX)47M share IPO priced at $16.00 Investment adviser Darwin Global Management became the third shareholder of Acceleron Pharmaceuticals ($XLRN) to publicly oppose the company’s pending acquisition by Merck ($MRK). In a letter, Darwin said it believes Merck’s $11 billion offer price, or $180 per share, is too low. Acceleron is actually worth between $22 billion and $28 billion, according to the firm, or $353 to $451 per share Industrials & Materials CSX Corp. ($CSX) 3Q EPS $0.43 vs est. $0.39 on revs $3.29B vs est. $3.11B; 24% surge in revenue just outpaced a 23% increase in expenses. Activist investor Elliott Management Corp. has a big stake in Canadian National Railway Co. ($CNI), the WSJ reported citing people familiar with the matter said, adding to pressure on the railroad after its CEO resigned following a failed bid for rival Kansas City Southern. Covenant Logistics ($CVLG) 3Q adj EPS $1.02 vs est. $1.02 on revs $274.6Mm vs est. $259.9Mm Dow Inc. ($DOW) Q3 EPS $2.75 vs. est. $2.56; Q3 revs $14.84B vs. est. $14.25 Graco ($GGG) 3Q adj EPS $0.57 vs est. $0.63 on revs $486.7Mm vs est. $490.5Mm; says continue to target mid-high-teen organic sales growth on constant currency basis for FY21 vs est. +19% Kaiser Aluminum ($KALU) Q3 adj EPS $0.57 vs. est. $1.33; Q3 sales $751M misses the $773.2M est.; anticipates cost issues and supply chain disruptions will continue during quarter Landstar ($LSTR) Q3 EPS $2.58 vs. est. $2.49; Q3 revs $1.734B vs. est. $1.66B; Q3 truckload transportation revenue hauled via van equipment inQ3 was up 59% YoY to $918.1M; truckload transportation revenue hauled via unsided/platform equipment in Q3 was up 44% to $423.0M; sees Q4 EPS $2.55-$2.65 vs. est. $2.43 PPG Industries ($PPG) 3Q adj EPS $1.69 vs est. $1.58 on sales about $4.4B vs est. $4.24B; guides FY adj EPS $6.67-6.73 vs est. $7.03; says plan to execute share repurchases in 4Q and continue to evaluate potential bolt-on acquisitions; say increased supply disruptions negatively impacted sales and manufacturing costs Rush Enterprises ($RUSHA) Q3 EPS $1.20 vs. est. $0.96; Q3 revs $1.27B below est. $1.34B; said supply chain issues continue to impact new truck and aftermarket sales Valmont Industries ($VMI) 3Q adj EPS $2.57 vs est. $2.47 on revs $868.8Mm vs est. $862.3Mm; guides FY adj EPS $10.60-11.10 vs est. $10.78; sees FY22 sales +7-12% vs est. +6.2%, sees EPS +13-15% vs est. +13.5%

Monday, October 18, 2021 U.S. equity futures are looking lower after posting strong gains last week, with oil prices extending their near-term rally into a ninth consecutive week, as concerns over surging inflation pressures and the weakest China growth rate in more than a year tamed optimism linked to a strong start to the third quarter earnings season. Chinese Q3 GDP missed, rising +0.2% q/q vs 0.5% consensus, and was +4.9% y/y vs 5.2% consensus amid a rolling power crisis, supply chain disruptions and a crackdown on the tech sector. In the U.S., the earnings flood begins this week with 72 names in the S&P 500 expected to report quarterly results this week. In corporate news today, Apple (AAPL) is holding its second major launch event of the Fall where it is expected to unveil the first redesign of its MacBook Pro laptop in at least five years (starts at 1:00 PM ET). In Asian markets, The Nikkei Index dipped -43 points to 29,025, the Shanghai Index slipped a few points to settle at 3,568, and the Hang Seng Index rose 78 points to 25,409. In Europe, the German DAX is lower by -0.6% or nearly 100-points to drop below 15,500, while the FTSE 100 dips -0.3% to hold above the 7,200 level. U.S. stocks look to build on last week’s gains where large-cap tech names propelled the advance Friday, with shares of Amazon.com (AMZN) and Tesla (TSLA) each rising more than 3% on no specific news, while the SmallCap Russell 2000 underperformed, falling -0.35% as investors bailed on value stocks for growth stocks. Strong quarterly earnings from Dow component Goldman Sachs (GS) also boosted financials as investors prepare for a flood of reports next week. Shares of cryptocurrency and blockchain-related firms gained last week as bitcoin topped $60,000 for the first time since April, with expectations growing that U.S. regulators would allow a futures-based ETF. Market Closing Prices Yesterday The S&P 500 Index jumped 33.11 points, or 0.75%, to 4,471.37 The Dow Jones Industrial Average rose 382.20 points, or 1.09%, to 35,294.76 The Nasdaq Composite climbed 73.91 points, or 0.50%, to 14,897.34 The Russell 2000 Index declined -8.52 points, or 0.37% to 2,265.65 Events Calendar for Today 9:15 AM ET Industrial Production MoM for September…est. +0.2% 9:15 AM ET Capacity Utilization for September…est. 76.5% 10:00 AM ET NAHB Housing Market Index for October…est. 76 4:00 PM ET Net Long-term TIC Flows for August Earnings Calendar: Earnings Before the Open: ACI, GNTY, STT Earnings After the Close: CFB, ELS, FBK, FNB, HXL, PACW, SFBS, STLD, ZION Other Key Events: Apple (AAPL) announces October 18th event (New MacBooks, a Mac Mini, and AirPods are anticipated) Macro Up/Down Last Nymex 1.43 83.71 Brent 1.11 85.97 Gold -6.70 1,763.50 EUR/USD -0.0012 1.1586 JPY/USD 0.15 114.37 10-Year Note +0.042 1.618% World News China’s industrial output rose +3.1% in September from a year earlier, missing expectations of up +4.5%, and slowing from 5.3% in August, official data showed. Retail sales grew +4.4% in September on-year, compared with a forecast 3.3% increase and a 2.5% rise in August. Fixed asset investment increased +7.3% in the first nine months from the same period a year earlier, missing expectations for a +7.9% rise Chinese Q3 GDP missed, rising +0.2% q/q vs 0.5% consensus; +4.9% y/y vs 5.2% consensus; Chinese Q3 GDP YTD missed +9.8% y/y vs 10.1% consensus; Chinese Sep Unemployment Rate lower: 4.9% vs 5.1% consensus Sector News Breakdown Consumer Lennar ($LEN) said its board increased share repurchase authorization by up to the lesser of $1 billion in purchase price, or 25 million in shares, of the outstanding Class A or Class B common stock Zillow Group ($ZG) is taking a break from buying U.S. homes after the online real estate giant’s pivot into tech-powered house-flipping hit a snag, Bloomberg reported saying after buying more than 3,800 homes in Q2, it will stop pursuing new home purchases as it works through a backlog of properties already in its pipeline Energy, Industrials and Materials S. crude oil futures closed at fresh seven-year highs last week at $82.28 for WTI crude and $8.86 for Brent as a natural gas supply crunch in Europe and optimism about demand in the U.S. continued to propel the recent rally. For the week, WTI rose 3.7% and Brent added 3%, the eighth straight weekly gain for both. Occidental Petroleum ($OXY) upgraded to Buy from Hold at Truist Steel Dynamics ($STLD) downgraded to Equal Weight from Overweight at Morgan Stanley and firm also downgraded S. Steel (X) to Underweight from Equal Weight Virgin Galactic ($SPCE) downgraded to Sell from Neutral at UBS with $15 tgt Healthcare Biogen Inc’s ($BIIB) said a late-stage experimental treatment for an inherited form of amyotrophic lateral sclerosis (ALS) failed to reach its main goal, but secondary measures and biomarkers showed favorable trends. Tofersen is designed to suppress the production of SOD1, a protein that can accumulate to toxic levels in ALS patients with mutations in a specific gene. Revance ($RVNC) shares fell over -30% late Friday after the FDA declined to approve its frown line injection treatment, citing issues with the company’s manufacturing facility; o other concerns were raised by the agency Avadel ($AVDL) shares slide over -20% after saying the U.S. FDA notified the co that the agency is still reviewing the marketing application of its sleep disorder drug, FT218, and the decision will likely not be taken this month (prior review was expected by Oct. 15) Omeros Corporation ($OMER) said they received a Complete Response Letter (CRL) from the U.S. FDA regarding its Biologics License Application ($BLA) for narsoplimab in the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy ($HSCT-TMA). PTC Therapeutics ($PTCT) downgraded to Underperform from Neutral at Bank America with a $38 price target Oyster Point Pharma ($OYST) announced that the FDA has approved Tyrvaya Nasal Spray 0.03 mg for the treatment of the signs and symptoms of dry eye disease MeiraGTx ($MGTX) mentioned positively in Barron’s saying shares could more than double as the company will present its gene-regulating “switches” at next week’s conference of the European Society of Gene and Cell Therapy, and to Wall Street investors in mid-December. Notes shares have fallen from a 2019 peak of $30 to a recent $14, leaving its market cap below $600 million The plan to roll out Merck & Co’s ($MRK) promising antiviral pill to treat COVID-19 risks repeating the inequities of vaccine distribution, potentially leaving the nations with the greatest need once again at the back of the line, international health groups say – Reuters Technology, Media & Telecom Dell Inc. ($DELL) with a positive mention in Barron’s saying the company is about to become much more attractive to investors as it prepares to spin off its valuable stake in software maker VMware (VMW) in early November, arguing that Dell will emerge with a solid balance sheet and simpler structure. Netflix ($NFLX) estimates that its latest megahit, “Squid Game,” will create almost $900 million in value for the company, and only cost about $21M to make. Netflix estimates that 89% of people who started the show watched at least 75 minutes – more than one episode – and 66% of viewers, or 87 million people, have finished the series in the first 23 days Disney ($DIS) downgraded to Equal Weight from Overweight at Barclays and cut tgt to $175 from $210 Members of a congressional committee questioned whether Amazon (AMZN) executives misled them during an investigation of the company’s business practices and if they may have lied under oath – WSJ reports Upstart ($UPST) downgraded to Underperform from Neutral at Bank America saying the LT thesis intact, but near-term upside priced in

Monday, October 11, 2021 U.S. stock futures are edging lower ahead of the Columbus Day holiday, with oil prices extending last week gains and moving to fresh 7-year highs ahead of key inflation data later this week and the upcoming earnings season, which starts Friday with the big banks ($JPM, $Citi). Over the weekend, Goldman Sachs cuts its 2021 economic growth forecast by 10 basis points, to 5.6%, while lowering its 2022 estimate by 40 basis point to 4% citing a “longer lasting virus drag on virus-sensitive consumer services” and the impact of an extended shortage in global semiconductors. The bond market is closed today in observance of the Columbus Day holiday after the 10-year yield closed at 1.612% on Friday, the highest level of the week. Oil prices extending gains, as WTI crude rises over $2.20 or 2.8% above $81.50. In Asian markets, The Nikkei Index rose 449 points (1.6%%) to 28,498, the Shanghai Index was little changed at 3,591, and the Hang Seng Index jumped nearly 2% or 487 points to settle at 25,325. In Europe, the German DAX is down about -50 points to 15,150, while the FTSE 100 is up about 0.25% at 7,110. Q quiet day expected ahead with no economic data and bond markets closed. Market Closing Prices Yesterday · The S&P 500 Index dropped -8.42 points, or 0.19%, to 4,391.34 · The Dow Jones Industrial Average fell -8.69 points, or 0.03%, to 34,746.25 The Nasdaq Composite slid -74.48 points, or 0.51%, to 14,579.54 · The Russell 2000 Index declined -17.00 points, or 0.76% to 2,233.09 Events Calendar for Today · No Major Economic Data Earnings Calendar: · Earnings Before the Open: AZZ, ENZ, FAST · Earnings After the Close: PNFP, SGH Other Key Events: · American Society of Retina Specialists Annual Scientific Meeting, in San Antonio, TX 10/8-10/12 World News · Goldman Sachs cuts its forecast for U.S economic growth over the weekend, citing a “longer lasting virus drag on virus-sensitive consumer services” and the impact of an extended shortage in global semiconductors. Goldman trimmed its 2021 growth forecast by 10 basis points, to 5.6%, while lowering its 2022 estimate by 40 basis point to 4%, adding that consumer spending is likely to be held back by pandemic uncertainty and a softer-than-expected fiscal response from the Biden administration. · Taiwan will keep bolstering its defenses to ensure nobody can force them to accept the path China has laid down that offers neither freedom nor democracy, President Tsai Ing-wen said on Sunday – Reuters Sector News Breakdown Consumer · Southwest Airlines ($LUV) cancelled 808 flights yesterday and has cancelled another 1,006 today, according to data from Flightaware.com. The company blamed the disruption on air traffic control issues and weather, although other major airlines are not delaying or cancelling flights at an elevated rate. There was speculation that some Southwest employees have called in sick in a form of protest over the mandatory vaccination rules in place, which have been unconfirmed · Hasbro ($HAS) said CEO Brian Goldner will take a medical leave of absence, effective immediately, slightly more than a year after disclosing that he was undergoing continued medical care following treatment for cancer in 2014. Energy, Industrials and Materials · Honeywell ($HON) raised its business outlook for jet deliveries on Sunday as travel restrictions ease as they now see 7,400 new business jet deliveries worth $238 bln over the next 10 years, up 1% from the same 10-year forecast a year ago. Business jet operators surveyed by Honeywell reported a sharp increase in their used jet purchase plans, 12% above last year’s report · Emerson Electric ($EMR) plans to merge two of its software businesses with Aspen Technology (AZPN) in a roughly $11B deal that values Aspen at around $160 a share, as shareholders would receive $87 and 0.42 share of the combined company for each share they currently own – WSJ https://on.wsj.com/3FxyVx7 · Cleveland-Cliffs ($CLF) agrees to acquire Ferrous Processing and Trading, one of the largest processors and distributors of prime ferrous scrap in the U.S., in a deal with an enterprise value of ~$775M. · Tutor Perini’s ($TPC) joint-venture signed a contract valued at ~$178 million by the U.S. Department of the Interior, Bureau of Reclamation, for the Friant-Kern Canal Middle Reach Capacity Correction Phase I project in central California, southeast of Visalia. Financials · Prudential ($PRU) mentioned positively in Barron’s saying for many years, Prudential Financial’s stock had a nice yield, but it didn’t offer much capital appreciation. The pandemic didn’t help, as the shares lost about 12% last year, dividends included, versus an 18% return for the S&P 500 index. But the market has changed its view, partly owing to an uptick in rates. On top of that, Prudential, whose businesses include life insurance, variable annuities, and asset management, is getting some credit for more-consistent earnings in recent years. Healthcare · Supernus Pharmaceuticals, Inc. ($SUPN) to acquire Adamas Pharmaceuticals, Inc. (ADMS) through a tender offer for $8.10 per share in cash (or an aggregate of approximately $400 million), payable at closing plus two non-tradable contingent value rights (CVR) collectively worth up to $1.00 per share in cash (or an aggregate of approximately $50 million), for a total consideration of $9.10 per share in cash (or an aggregate of approximately $450 million). · AstraZeneca ($AZN) Phase 3 trial met its primary end point; trial showed a reduced risk of death & severe C-19 by 67% in a trial where 90% of participants were from high-risk categories; only long acting antibody combination that can both prevent & treat C-19 · Merck ($MRK) submitted an Emergency Use Authorization (EUA) application to the U.S. FDA for molnupiravir, an investigational oral antiviral medicine, for the treatment of mild-to-moderate COVID-19 who are at risk for progressing to severe COVID-19 and/or hospitalization · Regenxbio ($RGNX) announces initial data from the ongoing Phase II ALTITUDE trial of RGX-314 for the treatment of diabetic retinopathy (DR) without center-involved diabetic macular edema (CI-DME) using in-office suprachoroidal delivery. · BeiGene ($BGNE) announced that BRUKINSA has been approved in Australia for the treatment of adult patients with mantle cell lymphoma who have received at least one prior therapy Technology, Media & Telecom · Apple ($AAPL) asked a federal appeals court on Friday to throw out a legal decision that would require the tech giant to tweak its strict App Store rules and force it to allow app developers to inform customers of ways to pay for subscriptions and services outside the App Store – NYT · Gray Television ($GTN) a positive mention in Barron’s saying at about $23.50 a share, it has a price/earnings ratio of five based on 2022 estimates. It looks like an inexpensive way to bet on broadcast as Gray’s strength in local news helps it make a killing in political ads · Toshiba Corp ($6502.T) said it would announce the results of a strategic review of its business along with its quarterly earnings results and a new mid-term business plan on Nov. 12. A spokesperson said the results of Toshiba’s strategic review would be part of the new business plan. The company had previously said the review would be announced this month. · U.S.-listed Chinese tech stocks Alibaba ($BABA), JD.com ($JD) and Baidu ($BIDU) among market leaders early; BABA shares up over 5% after Reuters noted the Daily Journal Corp, chaired by Berkshire Hathaway Vice Chairman Charlie Munger, boosted its holdings in BABA by 83% during Q3, according to public disclosures. Also helping sentiment in China listed stocks, China’s antitrust regulator also fines delivery giant Meituan 3.4 bln yuan ($527.4 mln), a smaller than expected figure, for abusing its dominant market position · Comcast ($CMCSA) downgraded to Market Perform from Outperform at Raymond James

$AFRM + $TGT Sezzle P-Ships $ELAN + Starboard $HUN + Starboard $ARCT, $MRTX + $MRK targets $MRVL + Guidance $M + Jana calls E-Commerce spin

$mrk 85 calls 10/22 0.30

1.8 Mil $MRK @ 82.9

UNUSUALLY HEAVY OPTION VOLUME TODAY: MERCK $MRK WILLIAMS COMPANIES $WMB DIAMONDBACK ENERGY $FANG CONSTELLATION BRANDS $STZ OCCIDENTAL PETROLEUM $OXY

Unusually active option classes on open October 4th $ADVM $TGP $VTNR $PROG $EA $MRK $BTU $XLE $OXY

3.5 Mil $MRK @ 84.2

$TSLA & $MRK added ti watch.

$MRK looks like it has a lot of room to run

1510 $MRK Jun 2022 95.0 Calls trade $2.28 (CboeTheo=2.13) ASKSIDE PHLX IV=24.5% +1.4 - OPENING Vol=2343, OI=131,

$MRK , who has info on this drug, does it seem legit?

1540 $MRK JUN2022 $95 Cs trade 2.32

1540 $MRK JUN2022 $95 Cs trade 2.32

The longer term play makes more sense to me > @Marcosx said: $MRK keeps contradicitng its action lol

$MRK keeps contradicitng its action lol